Review:
Trends of Robot Therapy with Neurological Therapeutic Seal Robot, PARO
Takanori Shibata*,**,*** and Joseph F. Coughlin**
*Human Technology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan
**The AgeLab., Massachusetts Institute of Technology, 77 Massachusetts Ave, E40-279, Cambridge, MA 02139, USA
***Interdisciplinary Graduate School of Science and Engineering, Tokyo Institute of Technology, Japan
Therapeutic robot PARO
Seal robot PARO is a neurological therapeutic robot for non-pharmacological therapy and, such as animal therapy, has no negative side effects. It has therapeutic effects on those from children to the elderly, particularly those with some cognitive impairment. PARO is used for two reasons. One is for activities to enable users to enjoy using PARO. The other is for medical therapy for specific patients with goals. In this paper, we detail the results of clinical experiments done on those mostly diagnosed with dementia. Experiments were conducted with PARO used for both cognitive and physical rehabilitation, in which PARO was used in activities and in therapy. Both types of cases showed positive effects in therapy and a reduction in the use of antipsychotic medications.
- [1] S. Carda, M. Invernizzi, A. Baricich, C. Comi, A. Croquelois, and C. Cisari, “Robotic gait training is not superior to conventional treadmill training in Parkinson disease: a single-blind randomized controlled trial,” Neurorehabilitation and neural repair, Vol.26, No.9, pp. 1027-1034, 2012.
- [2] J. Fasola, and M. Matarić, “A socially assistive robot exercise coach for the elderly,” J. of Human-Robot Interaction, Vol.2, No.2, pp. 3-32, 2013.
- [3] T. Shibata, “Therapeutic Seal Robot as Biofeedback Medical Device: Qualitative and Quantitative Evaluations of Robot Therapy in Dementia Care,” Proc. of the IEEE, Vol.100, No.8, pp. 2527-2538, 2012.
- [4] M. R. Banks, L. M. Willoughby, andW. A. Banks, “Animal-assisted therapy and loneliness in nursing homes: Use of robotic versus living dogs,” J. of the American Medical Directors Association, Vol.9, pp. 173-177, 2008.
- [5] H. Robinson, B. Macdonald, N. Kerse, and E. Broadbent, “The psychosocial effects of a companion robot: a randomized controlled trial,” J. Am. Med. Dir. Assoc., Vol.14, No.9, pp. 661-667, Sep. 2013.
- [6] A. Yokoyama, “What is Animal Therapy,” NHK Books, 1996.
- [7] Y. Kawaguchi et al., “Investigation of Brain Activity during Interaction with Seal Robot by fNIRS,” Proc. of IEEE RO-MAN 2011, pp. 308-313, 2011.
- [8] W. Moyle et al., “Exploring the Effect of Companion Robots on Emotional Expression in Older Adults With Dementia – A Pilot Randomized Controlled Trial,” J. of Gerontological Nursing, Vol.39, No.5, pp. 46-53, 2013.
- [9] R. Eskander et al., Society of Gynecologic Oncologists (SGO), 44th Annual Meeting on Women’s Cancer, 351, 2013.
- [10] A. Burton, “Dolphins, dogs, and robot seals for the treatment of neurological disease,” Lancet Neurology, Vol.12, Issue 9, pp. 851-852, Sep. 2013.
- [11] Proc. of the 1st Int. Symposium on Robot Therapy with PARO, Tokyo, Sep. 29, 2012.
- [12] Proc. of the 2nd Int. Symposium on Robot Therapy with PARO, Tokyo, February 16, 2013.
- [13] Proc. of the 3rd Int. Symposium on Robot Therapy with PARO, Osaka, June 29, 2013.
- [14] Proc. of the 4th Int. Symposium on Robot Therapy with PARO, Tokyo, November 30, 2013.
- [15] T. Kidwood, “Dementia Reconsidered: the Person Comes First,” Open University Press, 1997.
- [16] N. Nishimura et al., “Clinical Case Studies of Application of PARO to Recovery Rehabilitation,” Proc. of the 2nd Symposium on Robot Therapy with PARO, pp. 45-48, 2013.
- [17] K. Matsuda, “Clinical Application of PARO to Recovery Rehabilitation,” Proc. of the 3rd Symposium on Robot Therapy with PARO, pp. 35-40, 2013.
- [18] L. Lauth and L. Plank, “PARO Study,” Report of Vincentian Collaborative System, 2010.
- [19] D. Noronha et al., “Robotic Therapy in Long-Term Care,” APA Annual Convention, 2012.
This article is published under a Creative Commons Attribution-NoDerivatives 4.0 Internationa License.